Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon : vimarsana.com

Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon

IRVINE, Calif., April 23, 2024 -- Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,...

Related Keywords

United States , David Nakasone , Adrienne Kemp , Tarsus Pharmaceuticals Inc , Nasdaq , Corporate Communications , Exchange Commission , Pharmakon Advisors , Maturity Date , Biopharma Credit , Tarsus Pharmaceuticals , Meibomian Gland Disease , Tarsu Form , Markets ,